SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...
The team at Healix would like to thank all the healthcare heroes who are on the front lines treating patients during this unprecedented time with the COVID-19 crisis. We know you are faced with new challenges every day, and we are sincerely grateful, now more than...
Healix is proud to celebrate over 30 years of infusion excellence. Since its founding in 1989, the company has revolutionized infusion therapy nationwide within the physician office site of care, maintaining a steadfast focus on providing patient and physician peace...
Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®, Octapharma’s new 16.5% Subcutaneous Immune Globulin. SUGAR LAND, TX ( May 29, 2019) – Healix Infusion Therapy is pleased to announce that it has been selected as a limited...
Healix, the nation’s leader in providing physician office-based infusion services, will implement the Citus Health digital solution suite to streamline multi-office healthcare communications and automate documentation workflows to provide the highest-quality patient...
SUGAR LAND, TX (December 6, 2018) – Healix, the nation’s leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow software application purpose-built for infusion...
Recent Comments